Primary antibodies targeted FOXO4, Leydig cell markers (StAR, CYP11A1, 3-HSD), spermatogenesis markers (PCNA, PLZF, UCHL1, SCP3), and senescence/apoptosis markers (Ser15-phospho-p53)
DSIP is supplied for laboratory research only
Cycle Length, Dosing and How to Sustain the Result AOD-9604 is typically prescribed in 6 to 12 week structured cycles followed by a 4 to 8 week rest period
The chart below provides complete dosage recommendations organized by your primary goal, including administration method, dose range, frequency, and expected cycle duration
However, any combination approach should be undertaken with medical supervision and careful monitoring of cumulative effects
Reconstituted solutions demonstrate stability for 2-3 weeks at 2-8C when protected from light and oxygen